Department of
In a recent study published in Cell, Professor of Anesthesiology, Qin Liu, PhD, and her team at Washington University School of Medicine in St. Louis have identified the specific neurons that trigger sneezing and coughing in mice. This discovery marks a significant advancement in our understanding of these fundamental reflexes, with potential implications for managing respiratory symptoms in humans.
The 2024 Anesthesiology Summer Research (ASSURE) Fellowship Program welcomed nine exceptionally bright and enthusiastic undergraduate students for an intensive 10-week summer-long journey.
Dr. Nahman-Averbuch is leading two studies to help predict who is at risk of developing migraine disorder, and to identify the changes in brain connectivity and hormone levels that precede the onset of migraine headaches in adolescents.
A research study led by Dr. Majumdar and his team, published in ACS Science Central on Wednesday, July 17, introduces a promising strategy for developing safer opioid medications.
Nokomis Ramos-Gonzalez, PhD, a postdoctoral trainee at Washington University School of Medicine in St. Louis, recently received a 2024 PhRMA Foundation Postdoctoral Fellowship in Drug Discovery. Her research focuses on developing new painkillers with fewer negative side effects.
Melissa Hector-Greene, MD, PhD, was recently awarded a Mentored Research Training Grant from the Foundation for Anesthesia Education and Research.
New research supports earlier findings that indicate that anesthesia is no more hazardous for the brain at higher doses than at lower doses.
Jessi Cucinello-Ragland, PhD, has been named a recipient of the 2024 NIH Outstanding Scholars in Neuroscience Award Program (OSNAP).
Three researchers from the Department of Anesthesiology, Khairunisa Binte Mohamad Ibrahim, PhD, Kyle Parker, PhD, and Mitsukuni Yoshida, MD, PhD, are among the recipients of this year’s McDonnell Center for Systems Neuroscience Small Grants.
Brian Ruyle, PhD, a postdoctoral fellow in the Moron-Concepcion Lab, has been selected to present his research on opioid-induced respiratory depression at the 17th Annual Countermeasures Against Chemical Threats (CounterACT) Network Research Symposium. Additionally, he is one of just 10 trainees awarded a travel grant, providing him with the necessary funds to attend the event in Salt Lake City, Utah, on June 3-5, 2024.